Document:

Side agreement to employment agreement

 Exhibit 10.2 
 April 21, 2008 
 Roger Prevot 
 [Address redacted]

 Dear Roger: 
 This letter will confirm that
your resignation from the Graham Packaging Company L.P. (“Company”) shall be effective on April 30, 2008 (the “Date of Termination”). 
 The terms and conditions of the termination of your employment will be in accordance with your Employment Agreement. Except to the extent specifically modified in this letter of agreement (the “Agreement”),
you are entitled to receive the benefits and payments set forth in Section 7.4 of the Employment Agreement. 
 Salary
Continuation 
 Your Annualized Total Compensation (defined in the Employment Agreement) will be paid monthly in the amount of
$72,759.75 from May 1, 2008 through April 1, 2010. These monthly payments are based on an annual base salary of $505,065.60 and the average annual bonus for the prior three years, $368,051.40. Your aggregate payment over the 24 month
period will be $1,746,234.00. These amounts remain subject to applicable withholding. 
 Prorata Bonus

 In the event that Graham’s 2008 Incentive Program performance criteria is met, then you shall receive a Prorata Annual Bonus in
accordance with the 2008 Incentive Program terms and conditions at the time the Annual Bonus would have otherwise been payable had you still been employed with the Company (but in no event shall such amount, if any, be paid later than
December 31, 2009). To the extent payable, the pro-rated bonus shall be calculated as follows: 
 Projected Incentive target: 183%

 Base Salary: $505,065.60 
 Pro-rated for 4 months: actual amount to be determined based on actual achievement of Incentive Program criteria. Failure to meet minimum criteria under the Incentive Program will result in no amount being paid. 
 Benefits Continuation 
 Effective April 30, 2008 you will no longer participate in any of the benefit plans of the Company or its affiliates except that you will continue to receive health insurance benefits for yourself and your dependents, as applicable,
subject to the limitations set forth below. Your contributory health insurance will be continued through April 30, 2010, provided that you continue to make the required weekly health contributions (currently $80.52 per week for medical and
dental insurance). Any reimbursement for proper medical expenses will be made as promptly as administratively feasible following submission of the related claim, but in no event later than December 31, 2011. Your eligibility to receive
continued health insurance coverage as required by COBRA (Section 4980 of the Internal Revenue Code of 1986, as amended) will run concurrently with your severance period and, therefore, you will not be eligible to continue your health insurance
coverage after April 30, 2010. Please contact Dawn Almoney if you wish to discuss converting your group life insurance to an individual policy. Notwithstanding the foregoing, in the event that you become eligible to receive comparable benefits
from a new employer, any benefits then provided to you by the Company or its affiliates will immediately cease. 

 Accrued Compensation 
 Immediately following your Date of Termination, you will receive a lump sum amount equal to the sum of your Accrued Base Salary (as defined in the
Employment Agreement), accrued but unpaid vacation for fourteen (14) vacation days and unpaid business expenses properly incurred by you in accordance with Company policy. 
 Pension Plan 
 You should contact Fidelity at 800-835-5097 to initiate the withdrawal or rollover of your 401(k) money. You may also elect to leave the money in the plan if you wish; however, you may not continue active participation in the plan and
therefore 401(k) deductions and any loan repayments will not be taken from your weekly severance payments. 
 Outplacement
Services 
 You will be entitled to receive Executive Career Transition Services (as defined in the Employment Agreement)
through the earlier of the first anniversary of your Date of Termination or the time at which you become employed on a substantively full-time basis. In no event shall this benefit exceed $30,000 in the aggregate. Any reimbursement for Executive
Career Transition Services will be made as promptly as administratively feasible following submission of the claim, but in no event later than December 31, 2011. 
 Restrictive Covenants 
 As a condition to receive any of the payments and
benefits set forth in this Agreement, you must remain in compliance at all time with each of the provisions of the agreement that you entered into with the Company relating to confidentiality of Company information and treatment of intellectual
property, in each case during employment and thereafter (the “Confidentiality Agreement”) and each of the restrictive covenants set forth in Article VIII of the Employment Agreement. These restrictive covenants include but are not limited
to non-solicitation of Company employees, non-competition, confidentiality and covenants relating to intellectual property. 
 Treatment of Equity Awards 
 Upon your termination of employment on April 30, 2008, the options to
purchase limited partnership units in Graham Packaging Holdings Company, L.P. (“Graham”) granted to you on February 2, 1998, as such grant was amended on January 21, 2008 (the “1998 Grant”), January 1, 1999 (the
“1999 Grant”), April 2, 2001 (the “2001 Grant”) and March 7, 2008 (the “2008 Grant”) (collectively the “Options”) will vest and become exercisable and will be exercisable anytime beginning
April 30, 2008 until either a Change in Control as defined in your Employment Agreement (provided that the Company will provide you with reasonable advance notice sufficient to allow you to exercise before the closing of a Change in Control),
or the expiration of each option grant, whichever is earlier. If any of the Options are not exercised as specified, such Options will be cancelled, and you will not be able to exercise them. 
 Except as set forth in this Agreement, such Options will remain subject to the terms and conditions of the Management Option Plan (the “Plan”)
and the applicable Non-Qualified Option Agreement (the “Option Agreements”) currently in place between you and the Company. Notwithstanding the provision of your Option Agreements that provides Graham the right to call your outstanding
Options and Option Units following your termination of employment, your Options and any Units acquired upon your exercise of any Option(s) may only be purchased by Graham upon the occurrence of any of the following events (i) you become an
employee or consultant of any Competitor (as defined in the Employment Agreement), (ii) you make a financial investment in any Competitor on behalf of yourself or any member of your family, (iii) you violate any of the restrictive
covenants set forth in Article VIII of the Employment Agreement, (iv) within six months following an initial Public Offering (as defined in the Plan), or (v) upon a Change in Control (as defined in the Option Agreements). Any such purchase
by Graham shall be at Fair Market Value (as defined in your Option Agreements). Notwithstanding any prior discussions or agreements, you will not receive any additional option grants. 
 You hereby confirm and agree that, subsequent to the Date of Termination, you remain a party to and are bound by the terms and conditions of (i) the
Management Stockholders’ Agreement, dated as of February 3, 1998, among Blackstone Capital Partners III Merchant Banking Fund L.P., Blackstone Offshore Capital Partners III L.P., Blackstone Family Investment Partnership III, L.P., 

  

 2 

 
BMP/Graham Holdings Corporation, Graham, GPC Capital Corp. II, you and the other management investors named therein, as the same may be amended, supplemented
or otherwise modified from time to time (the “Stockholders Agreement”), (ii) the Registration Rights Agreement, dated as of February 2, 1998, among the Company, GPC Capital Corp. II, Graham Capital Corporation, Graham Family
Growth Partnership, BCP/Graham Holdings L.L.C., BMP/Graham Holdings Corporation and the other parties named therein, as the same may be amended, supplemented or otherwise modified from time to time, and (iii) the Promissory Notes, dated as of
September 28, 2000 and March 30, 2001, between you and the Company, as the same may be amended, supplemented or otherwise modified from time to time (the “Notes”), and the related Pledge Agreements, dated as of September 28,
2000 and March 30, 2001, between you and the Company, as the same may be amended, supplemented or otherwise modified from time to time. 
 Notwithstanding the foregoing, for so long as you comply with each of the restrictive covenants set forth in Article VIII of the Employment Agreement (i) Graham hereby agrees not to exercise its rights under Section 4 of the
Stockholders Agreement and (ii) the Company hereby agrees not to exercise its rights under Section 2 of the Notes and/or its related rights under the related Pledge Agreements. 
 You hereby covenant and agree that in connection with an underwritten public offering of equity securities of the Company you will not effect any sale or
distribution of your equity securities (including, but not limited to, your Options or Option Units or any successor equity or any securities convertible into or exchangeable or exercisable for such equity securities) for a period of not more than
180 days after the effective date of the registration statement relating to the offering of equity securities by the Company, and that you will enter into an agreement to that effect if so requested by the Company. 
 Continued Assistance 
 In exchange for the Treatment of Equity Awards, you agree to assist Graham in the following post-employment assignments: 
  

	 	•	 	 assisting in litigations-including the OI Indemnity Lawsuit, contract litigations, potential supplier related disputes and litigations, and other matters where your
input is required to defend or pursue any dispute 

  

	 	•	 	 introduction to and work with customers, if required, particularly customers that we are very close with 

  

	 	•	 	 provide status updates in the following: customer discussions/negotiations, other technology related matters, 

  

	 	•	 	 assistance in carve out related issues in case of organizational change 

  

	 	•	 	 cooperate in any board resolution issue as necessary. 

 Graham shall reimburse you for your out-pocket expenses incurred while carrying out these assignments. 
 Waiver and
Release 
 In consideration of receiving from the Company the payments and benefits provided for in this Agreement to which you
are not otherwise entitled, you agree to unconditionally and forever release and discharge the Company, its parents, subsidiaries and affiliates, and each of their respective officers, directors, partners, employees, agents, representatives and
attorneys, and each of their predecessors, successors and assigns (collectively, the “Releasees”) from any and all claims, causes of action, demands, obligations, lawsuits or other charges whatsoever, known or unknown, arising under or
relating to: (i) any rights or claims under the Employment Agreement; or (ii) any events occurring on or prior to the time you sign this Agreement including, but not limited to (a) any rights or claims directly or indirectly related
to your employment or the termination thereof; (b) any rights or claims under any employee benefit plans of the Company or its affiliates; (c) any rights or claims based on allegations of wrongful discharge, breach of contract, promissory
estoppel, defamation, infliction of emotional distress; and (d) any allegations of discrimination on the basis of age, race, color, sex, religion, national origin, disability, or any other basis; provided, however, that nothing in this release
shall prevent you from bringing appropriate proceedings based on: (i) a breach of the Company’s obligations under this Agreement; (ii) any right or claim under the Plan and the Option Agreements, in each case as modified and amended
by this Agreement; or (iii) any claims for vested benefits to which you are otherwise eligible to receive under any of the Company’s employee benefit plans, including but not limited to retirement, pension or health insurance plans. You
represent that you have not commenced or joined in any claim, charge, action or proceeding whatsoever against the Company or any of the Releasees arising out of or relating to any of the matters set forth in this Agreement. You further agree that
you will not be entitled to any personal recovery in any claim, charge, action or proceeding whatsoever against the Company or any of the Releasees for any of the matters set forth herein. 
  

 3 

 Non-Admission of Liability 
 The Company’s offer to you of this Agreement and the payments and benefits set forth herein is not intended to, and shall not be construed as, any
admission of liability to you or of any improper conduct on the part of the Company or any of the Releasees, all of which the Company and the Releasees specifically deny. 
 You acknowledge that the benefits and payments set forth in this Agreement are in full satisfaction of any benefit to which you were previously entitled. 
 Sincerely, 
  

	
	 /s/ George M. Lane

	Graham Packaging Holdings Company, L.P.
	George M. Lane
	Senior Vice President, Global Human Resources

 I have read the above information and fully understand and agree to the conditions of my termination effective
April 30, 2008. 
  

					
	 /s/ Roger Prevot
	 		 	4/21/08
	Roger Prevot	 		 	Date

  

 4Sixth Amendment to Loan Agreement

 Exhibit 10.261 
 SIXTH AMENDMENT TO LOAN AGREEMENT 
 THIS SIXTH AMENDMENT TO LOAN AGREEMENT (the “Amendment”),
dated as of July 1, 2008, is made by and among PHARMACEUTICAL PRODUCT DEVELOPMENT, INC. (the “Borrower”), PPD DEVELOPMENT, LP, (the “Guarantor”) and BANK OF AMERICA, N.A. (the “Bank”). 
 RECITALS: 
 A. The Borrower, the Guarantor and the
Bank entered into that certain Loan Agreement, dated as of July 25, 2002, as amended (the “Loan Agreement”). 
 B. The
Borrower, the Guarantor and the Bank have agreed to amend the Loan Agreement as set forth herein. 
 NOW THEREFORE, the parties hereto agree
as follows: 
 1. Section 1.01 of the Loan Agreement is amended by deleting the definition of “Committed Amount” and
replaced it with the following definition: 
 “Committed Amount” means the amount of the commitment of the Bank hereunder,
being $25,000,000. 
 2. Section 1.01 of the Loan Agreement is further amended by deleting the definition of “Termination
Date” and replacing it with the following definition: 
 “Termination Date” means June 30, 2009, or such later date as
to which the Bank may agree in its sole discretion. 
 3. Section 2.1 of the Loan Agreement is amended by replacing the reference to
“Fifty Million Dollars (“50,000,000)”contained therein with a reference to “Twenty-Five Million Dollars $25,000,000)”. 
 4. Sections 6.9 (c), 6.9 (d) and Section 6.9 (e) of the Loan Agreement are deleted. 
 5.
Except as hereby modified, all the terms and provisions of the Loan Agreement and exhibits thereto remain in full force and effect. 
 6. The
Borrower and the Guarantor acknowledge and agree that there are no defenses, setoffs or counterclaims available to them with respect to the performance of their obligations under the Loan Agreement (including, without limitation, the
Guarantor’s obligations under Section 3 of the Loan Agreement). 

 7. The Borrower and the Guarantor will execute such additional documents as are reasonably requested by
the Bank to reflect the terms and conditions of this Amendment and will cause to be delivered such certificates, legal opinions and other documents as are reasonably required by the Bank. In addition, the Borrower and the Guarantor will pay all
costs and expenses in connection with the preparation, execution and delivery of the documents executed in connection with this transaction, including, without limitation, the reasonable fees and out-of-pocket expenses of special counsel to the Bank
as well as any and all filing and recording fees and stamp and other taxes with respect thereto and to save the Bank harmless from any and all such costs, expenses and liabilities. 
 8. This Amendment may be executed in any number of counterparts, each of which when so executed and delivered shall be deemed an original, and it shall
not be necessary in making proof of this Amendment to produce or account for more than one counterpart. 
 9. This Amendment and all other
documents executed pursuant to the transactions contemplated herein shall be deemed to be contracts made under, and for all purposes shall be construed in accordance with, the internal laws and judicial decisions of the State of North Carolina. The
Borrower and the Guarantor hereby submit to the jurisdiction and venue of the state and federal courts of North Carolina for the purposes of resolving disputes hereunder and thereunder or for purposes of collection. 
 IN WITNESS WHEREOF, the parties hereto have caused this Amendment to be executed by their fully authorized officers as of the day and year first above
written. 
  

							
	BORROWER:	 	PHARMACEUTICAL PRODUCT DEVELOPMENT, INC., a North Carolina corporation
			
		 	By:	 	 /s/ Daniel G. Darazsdi

		 	Name:	 	Daniel G. Darazsdi
		 	Title:	 	Chief Financial Officer
		
	GUARANTOR:	 	PPD DEVELOPMENT, LP,
		 	a Texas limited partnership
				
		 		 	By:	 	PPD GP, LLC,
		 		 		 	a Delaware limited liability company,
		 		 		 	its General Partner
				
		 		 	By:	 	 /s/ B. Judd Hartman

		 		 	Name:	 	B. Judd Hartman
		 		 	Title:	 	Vice President

			
	BANK OF AMERICA, N.A.
		
	By:	 	 /s/ Lynette M. Songy

	Name:	 	Lynette M. Songy
	Title:	 	Senior Vice President

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00145-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00145-of-00352.parquet"}]]